Healthcare and Medical News Line @HealthcareDirectUSA
Thermo Fisher will buy The Binding Site for $2.6B to gain specialty diagnostics portfolio
The U.K.-based firm makes two blood tests for multiple myeloma.
04:28 PM - Oct 31, 2022
Only people mentioned by HealthcareDirectUSA in this post can reply

No replies yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Healthcare and Medical News Line, click on at the bottom under it